Inflammatory Bowel Disease & Microbiota
Inflammatory Bowel Disease
February 1, 2017
GG Kaplan and SC Ng, Gastroenterology. 02, 2017. 152: p. 313-321.e312. [IF: 18.392]
The are contemporary conditions of industrialized societies. The global spread of inflammatory bowel diseases (IBDs) appears to associate with Westernization of diets and environments, w...
HCH Chan and SC Ng, 1. Journal of Gastroenterology. 02, 2017. 52: p. 141-150. [IF: 0.165]
Early biologic therapy is recommended in patients with inflammatory bowel disease and poor prognostic factors and in those refractory to conventional medications. Anti-tumor necros...
December 1, 2016
GG Kaplan and SC Ng, The Lancet Gastroenterology and Hepatology. 12, 2016. 1: p. 307-316.
The UK and China provide unique historical perspectives on the evolution of the incidence of infl ammatory bowel disease, which might provide insight into its pathogenesis. During...
April 1, 2013
SC Ng, CN Bernstein, MH Vatn, PL Lakatos, EV Loftus Jr, C Tysk, C O'Morain, B Moum, and JF Colombel, Gut. 04, 2013. 62: p. 630-649. [IF: 16.658]
The changing epidemiology of inflammatory bowel disease (IBD) across time and geography suggests that environmental factors p...
Our Recent Publications
Gut mucosal virome alterations in ulcerative colitis
January 21, 2020
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific
September 3, 2018
A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-medi...
May 11, 2018
Selected Journal Papers